Article
HLA-matched related-donor HSCT in Fanconi anemia patients conditioned with cyclophosphamide and fludarabine
8 Jan 2015
Abstract excerpt
To the editor: Fanconi anemia (FA) is a rare, phenotypically heterogeneous inherited disorder clinically characterized by congenital abnormalities, progressive bone marrow failure (BMF), and a predisposition to develop malignancies.[1][1] Hematopoietic stem cell transplantation (HSCT) is the only
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
